他克莫司
器官移植
免疫系统
移植
药理学
医学
环孢素
免疫抑制
移植排斥反应
肝移植
免疫学
内科学
作者
Jindao Wu,Zhen Zheng,Yuanyuan Chong,Xiangcheng Li,Liyong Pu,Qiyun Tang,Yang Liu,Xuehao Wang,Fuqiang Wang,Gaolin Liang
标识
DOI:10.1002/adma.201805018
摘要
Abstract Transplant rejection is the key problem in organ transplantation and, in clinic, immunosuppressive agents such as tacrolimus are directly administered to the recipients after surgery for T‐cell inhibition. However, direct administration of tacrolimus may bring severe side effects to the recipients. Herein, by rational design of two hydrogelators NapPhePheGluTyrOH ( 1 ) and Nap d ‐Phe d PheGluTyrOH ( 2 ), a facile method of immune responsive release of tacrolimus is developed from their hydrogels to overcome organ transplantation rejection. Upon incubation with protein tyrosine kinase, which is activated in T cells after organ transplantation, the tacrolimus‐encapsulating Gel 1 or Gel 2 is disassembled to release tacrolimus. Cell experiments show that both Gel 1 and Gel 2 have better inhibition effect on the activated T cells than free drug tacrolimus. Liver transplantation experiments indicate that, after 7 days of treatment of same dose tacrolimus, the recipient rats in the Gel 2 group show significantly extended median survival time of 22 days while the recipients treated with conventional tacrolimus medication have a median survival time of 13 days. It is expected herein that this “smart” facile method of immune responsive release of tacrolimus can be applied to overcome organ transplantation rejection in clinic in the near future.
科研通智能强力驱动
Strongly Powered by AbleSci AI